Keywords: USA, Cephalon, Nuvigil, Provigil, FDA, Jet lag, Pay-to-delay

US FDA calls for more data on Cephalon’s Nuvigil for jet lag sleepiness, as firm receives setback in pay-for-delay deal on Provigil

Article | 30 March 2010

Print This

US drugmaker Cephalon has received a Complete Response letter from the Food and Drug Administration for its supplemental new drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in